Cargando…
Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
Chronic graft-versus-host disease (cGVHD) is one of the most important causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). Occurring in 30% to 70% of patients, cGVHD has a median time to onset of 4 to 6 months and most cases present within 2 years afte...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646988/ https://www.ncbi.nlm.nih.gov/pubmed/26613052 http://dx.doi.org/10.1155/2015/692175 |
_version_ | 1782401011040649216 |
---|---|
author | Gunes, Gursel Demiroglu, Haluk Goker, Hakan Malkan, Umit Yavuz Eliacik, Eylem Yayar, Okan Buyukasik, Yahya |
author_facet | Gunes, Gursel Demiroglu, Haluk Goker, Hakan Malkan, Umit Yavuz Eliacik, Eylem Yayar, Okan Buyukasik, Yahya |
author_sort | Gunes, Gursel |
collection | PubMed |
description | Chronic graft-versus-host disease (cGVHD) is one of the most important causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). Occurring in 30% to 70% of patients, cGVHD has a median time to onset of 4 to 6 months and most cases present within 2 years after aHSCT. Here, we present a patient transplanted at the age of 55 who developed refractory cutaneous cGVHD more than 5.5 years after aHSCT. |
format | Online Article Text |
id | pubmed-4646988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-46469882015-11-26 Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease Gunes, Gursel Demiroglu, Haluk Goker, Hakan Malkan, Umit Yavuz Eliacik, Eylem Yayar, Okan Buyukasik, Yahya Case Rep Hematol Case Report Chronic graft-versus-host disease (cGVHD) is one of the most important causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). Occurring in 30% to 70% of patients, cGVHD has a median time to onset of 4 to 6 months and most cases present within 2 years after aHSCT. Here, we present a patient transplanted at the age of 55 who developed refractory cutaneous cGVHD more than 5.5 years after aHSCT. Hindawi Publishing Corporation 2015 2015-11-03 /pmc/articles/PMC4646988/ /pubmed/26613052 http://dx.doi.org/10.1155/2015/692175 Text en Copyright © 2015 Gursel Gunes et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Gunes, Gursel Demiroglu, Haluk Goker, Hakan Malkan, Umit Yavuz Eliacik, Eylem Yayar, Okan Buyukasik, Yahya Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
title | Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
title_full | Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
title_fullStr | Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
title_full_unstemmed | Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
title_short | Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease |
title_sort | late onset and protracted course of steroid refractory chronic graft-versus-host disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646988/ https://www.ncbi.nlm.nih.gov/pubmed/26613052 http://dx.doi.org/10.1155/2015/692175 |
work_keys_str_mv | AT gunesgursel lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease AT demirogluhaluk lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease AT gokerhakan lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease AT malkanumityavuz lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease AT eliacikeylem lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease AT yayarokan lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease AT buyukasikyahya lateonsetandprotractedcourseofsteroidrefractorychronicgraftversushostdisease |